Trieu Vuong

CHAIRMAN AND CEO

Trieu Vuong has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.

On the most recent filing, Trieu Vuong is listed as CHAIRMAN AND CEO at Oncotelic Therapeutics, Inc. Inside the rolling window, Trieu Vuong reported 6 open-market purchases totaling $37K in OTLC and no open-market sales. The largest disclosed transaction in the window is a purchase of 239,759 OTLC shares on Jun 17, 2026, worth $11K.

Companies traded

Other insiders at OTLC

Insider Buying

$37K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
OTLCPurchase$10KJul 2SEC ↗
OTLCPurchase$5KJun 25SEC ↗
OTLCPurchase$3KJun 25SEC ↗
OTLCPurchase$3KJun 25SEC ↗
OTLCPurchase$11KJun 17SEC ↗
OTLCPurchase$4KJun 17SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Trieu Vuong made?

Trieu Vuong has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.

Which companies does Trieu Vuong trade?

Trieu Vuong has filed SEC Form 4 disclosures for 1 company, including OTLC.

When was Trieu Vuong's most recent SEC Form 4 filing?

Trieu Vuong's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.

What is Trieu Vuong's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Trieu Vuong is listed as CHAIRMAN AND CEO.

What is Trieu Vuong's total buy and sell value in the current window?

Inside the rolling retention window, Trieu Vuong bought $37K and sold $0 based on SEC Form 4 filings.

What was Trieu Vuong's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 239,759 OTLC shares on 2026-06-17, worth $11K, per SEC Form 4 filings.